TGFB1 and neoplasm: However, TGF-β signaling involving both SMAD and non-canonical pathways can be hijacked during neoplastic transformation to promote tumor cell proliferation, epithelial-to-mesenchymal transition (EMT), and immunosuppression [9,11].